CIK 0001770787
- Large accelerated filer
10x Genomics, Inc.
Sign in to watch- Ticker
- TXG
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 455614458
- Phone
- +1 925-401-7300
- Business address
- 6230 STONERIDGE MALL ROAD, PLEASANTON, CA, 94588
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,605,538
- in 10 filings, $6.3M under 10b5-1 plans
Net −$12,605,538. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 87 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-08 | Venrock Associates VI, L.P. 10% owner | Other disposition | −731,308 | 2,306,517 | ||
| 2020-12-08 | Venrock Associates VI, L.P. 10% owner | Conversion · Class B Common Stock | −3,000,000 | 5,790,422 | ||
| 2020-12-08 | ROBERTS BRYAN E Director | Conversion | +3,000,000 | 3,037,825 | ||
| 2020-12-08 | ROBERTS BRYAN E Director | Other disposition | −731,308 | 2,306,517 | ||
| 2020-12-08 | ROBERTS BRYAN E Director | Conversion · Class B Common Stock | −3,000,000 | 5,790,422 | ||
| 2020-12-08 | Saxonov Serge Chief Executive Officer | Gift | −382 | 966,799 | ||
| 2020-12-01 | STUELPNAGEL JOHN R Director | Sale | −2,100 | $150.15 | $315K | 501,391 |
| 2020-12-01 | STUELPNAGEL JOHN R Director | Sale | −3,500 | $150.99 | $528K | 497,891 |
| 2020-12-01 | STUELPNAGEL JOHN R Director | Sale | −500 | $151.68 | $76K | 497,391 |
| 2020-12-01 | STUELPNAGEL JOHN R Director | Sale | −500 | $152.88 | $76K | 496,891 |
| 2020-12-01 | STUELPNAGEL JOHN R Director | Sale | −900 | $153.54 | $138K | 495,991 |
| 2020-12-01 | Saxonov Serge Chief Executive Officer | Exercise or conversion | +6,250 | $1.20 | $8K | 973,431 |
| 2020-12-01 | Saxonov Serge Chief Executive Officer | Exercise or conversion | +3,750 | $5.04 | $19K | 977,181 |
| 2020-12-01 | Saxonov Serge Chief Executive Officer | Sale | −3,004 | $150.01 | $451K | 974,177 |
| 2020-12-01 | Saxonov Serge Chief Executive Officer | Sale | −3,398 | $151.02 | $513K | 970,779 |
| 2020-12-01 | Saxonov Serge Chief Executive Officer | Sale | −1,091 | $151.92 | $166K | 969,688 |
| 2020-12-01 | Saxonov Serge Chief Executive Officer | Sale | −2,174 | $153.26 | $333K | 967,514 |
| 2020-12-01 | Saxonov Serge Chief Executive Officer | Sale | −333 | $153.84 | $51K | 967,181 |
| 2020-12-01 | Saxonov Serge Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) | −6,250 | 109,860 | ||
| 2020-12-01 | Saxonov Serge Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) | −3,750 | 124,515 |
Page 52 of 57 · 1,128 trades